The term monoclonal gammopathy of renal significance (MGRS) has been coined in 2012 to describe a group of renal disorders caused by a monoclonal immunoglobulin (M-protein) secreted by a nonmalignant plasma cell or B-cell clone [1–3]. The gene discussed is MYOM2; the disease is kidney disorder.